Xenetic Biosciences (XBIO) Return on Sales [ROS] (2011 - 2026)
Xenetic Biosciences (XBIO) posted Return on Sales [ROS] of -147.09% for Q2 2026, down 24.29 percentage points from -122.80% a year earlier and down 84.87 percentage points from the prior quarter.
Xenetic Biosciences (XBIO) Return on Sales [ROS] (2011 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Return on Sales [ROS] at Xenetic Biosciences was -81.01%, up 52.48 percentage points year-over-year; for FY2025, it was -95.23%, up 72.92 percentage points from FY2024.
- Annual Return on Sales [ROS] has increased for six consecutive years, with a five-year change of +3094.59 percentage points (FY2020 to FY2025).
- In prior years, Xenetic Biosciences' Return on Sales [ROS] was -168.16% in FY2024 (+9.63 pp), -177.79% in FY2023 (+215.78 pp), -393.57% in FY2022 (+101.55 pp) and -495.12% in FY2021 (+2694.70 pp).
- The Q2 2026 figure stands as the lowest quarterly Return on Sales [ROS] since Q1 2025.
- On a year-over-year basis, Return on Sales [ROS] increased in seven of the last eight quarters, with an average year-over-year change of +57.91 percentage points.
- The strongest year-over-year quarter for Return on Sales [ROS] in the past five years was Q3 2021, with a gain of 8666.71 percentage points; the weakest was Q2 2022, with a drop of 252.75 percentage points.
- According to Business Quant data, Return on Sales [ROS] for the three prior quarters was -62.23% (Q1 2026), -81.30% (Q4 2025) and -53.04% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 51.16% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 28.21% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 37.86% |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | -3.52% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 32.97% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 20.57% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 34.95% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -133.21% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 28.37% |
| 10 | Xenetic Biosciences | 5.25 Mn | -20.58 Mn | - | -147.09% |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -147.09% |
| Mar 31, 2026 | -62.23% |
| Dec 31, 2025 | -81.30% |
| Sep 30, 2025 | -53.04% |
| Jun 30, 2025 | -122.80% |
| Mar 31, 2025 | -158.85% |
| Dec 31, 2024 | -169.41% |
| Sep 30, 2024 | -81.32% |
| Jun 30, 2024 | -184.11% |
| Mar 31, 2024 | -248.31% |
| Dec 31, 2023 | -186.87% |
| Sep 30, 2023 | -187.62% |
| Jun 30, 2023 | -184.05% |
| Mar 31, 2023 | -151.06% |
| Dec 31, 2022 | -321.03% |
| Sep 30, 2022 | -204.66% |
| Jun 30, 2022 | -644.83% |
| Mar 31, 2022 | -416.39% |
| Dec 31, 2021 | -563.44% |
| Sep 30, 2021 | -393.97% |
Xenetic Biosciences Return on Sales [ROS] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=XBIO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-sales-[ros]", "ticker": "XBIO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=XBIO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();